Fernando, Pilar Gina E.

HRN: 21-23-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2022
CEFUROXIME 1.5GM (VIAL)
04/17/2022
04/17/2022
IVT
1.5g
LD
UTI
Waiting Final Action 
04/17/2022
CEFUROXIME 750MG (VIAL)
04/18/2022
04/22/2022
IVT
750mg
Q8
UTI
04/20/2022
MUPIROCIN 2%, 15G (TUBE)
04/20/2022
04/26/2022
TOPICAL
15mg
BID
Infected Post-op Wound
Waiting Final Action 
04/20/2022
CLINDAMYCIN 300MG (CAP)
04/20/2022
04/26/2022
ORAL
300mg
TID
Infected Post-op Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: